Perkins Coie’s Intellectual Property practice has market-leading capabilities in patent litigation, prosecution, analysis, licensing and technology transactions. We litigate patents in district courts across the United States and before the PTAB. Perkins Coie has one of the most active and most successful PTAB practices in the country. We have appeared as counsel of record in more than 290 inter partes reviews (IPRs) and other PTAB trials, and our practice is well balanced in representing petitioners and patent owners. And when cases go up on appeal, we have one of the leading Federal Circuit practices in the country. The IP practice also successfully prepares and prosecutes patent applications in anticipation of licensing opportunities and potential litigation. We manage clients’ patent portfolios and provide strategies for strengthening and monetizing those portfolios.
Our 225+ patent prosecutors and litigators have experience across a range of life sciences technologies, including biotechnology, pharmaceuticals (branded and generic), biologics, biosimilars, chemistry, diagnostics, medical devices and digital health. Several of our IP attorneys have advanced degrees in molecular biology, chemistry or biophysics, while others actively participate on boards of directors for various life sciences organizations, keeping them at the forefront of industry trends. We represent clients across a full range of life sciences industry segments and know the industry as well as we know the laws and regulations that apply to it.
Perkins Coie has been named U.S. News – Best Lawyers® “Law Firm of the Year” in Patent Law three times in six years, most recently for 2018, which is more so than any other firm. The firm was also recently recognized as the leading law firm representing America’s largest companies in IP litigation by Corporate Counsel. Perkins Coie is consistently named among the top ten firms representing parties before the PTAB by Lex Machina and Docket Navigator.
We were also ranked as the Top Life Sciences Law Firm in Patent Litigation for Q3 2017 by Lake Whillans Litigation Finance in its Life Sciences Law Firm Index, and our Life Sciences industry group is recognized nationally by U.S. News – Best Lawyers® and Chambers.